Want to join the conversation?
$VRTX 2Q15 Q&A: Matthew of UBS asked Stuart to elaborate on launch metrics. Pointing out that Vertex is less than four weeks in since the approval of ORKAMBI, Stuart refrained commenting on specific launch metrics. Because of the interest in the product and the unmet need, VRTX is expecting the overall penetration of ORKAMBI to be high, he said.
$TWTR mentions Snap as one of its fiercest rivals in its 10K filing. Great head start for Snap ahead of IPO!